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a  b  s  t  r  a  c  t
Aim: To analyse the long term swallowing function in head and neck cancer patients and
correlate with the dose to midline swallowing structures.
Background: The use of concurrent chemo radiation (CRT) as the present standard of care
resulted in high rates of early and late toxicities. Dysphagia, aspiration, and xerostomia are
early as well as late effects of radiation. Not many studies on the dysphagia scores during
radiation and follow-up period have correlated with dose to the swallowing structures, hence
this  study.
Materials and Methods: Histologically proven head and neck cancer patients treated with
intensity modulated radiation therapy were accrued in this study. The pharyngeal constric-
tors, larynx and cervical oesophagus were contoured and labelled as midline swallowing
structures. The volume of the midline swallowing structures which were outside the Plan-
ning  target volume (PTV) was delineated separately and was given a mean dose constraint
of  45 Gy. Dysphagia was assessed at baseline, weekly during irradiation and up to six years.
The  dose to the structures for swallowing was correlated with degree of dysphagia.
Results: There was a gradual increase in the dysphagia grade during the course of radiation.
There was significant recovery of late dysphagia compared to dysphagia during the com-
pletion of radiation therapy in patients who received <45 Gy to the swallowing structures
(p  < 0.0001).Conclusion: Giving a constraint to the swallowing structures and limiting it to <45 Gy resulted
in  earlier recovery of swallowing function resulted leading to good physical, mental and
social well being of the patients when compared to those who received >45 Gy.
©  2019 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.∗ Corresponding author.
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Fig. 1 – Contouring of constrictor muscle.reports of practical oncology and 
.  Background
ead and neck cancer (HNC) is the sixth most common can-
er worldwide, accounting for about 3.2% of all malignancies.1
n India, it accounts for 23% of all cancers in men  and 9% in
omen.2 Radiotherapy has a major role in the treatment of
NC owing to a complicated anatomic relationship between
he tumour and the normal structures in maintaining the
uality of life (QOL) of the patient. The use of concurrent
hemo radiation (CRT) as the present standard of care resulted
n a 19% reduction in the risk of death and an overall 8%
mprovement in five year survival compared with radiother-
py alone but with high rates of early and late mucosal and
haryngeal toxicities.3 Dysphagia, aspiration, and xerostomia
re important early as well as late effects of radiation ther-
py that have significant QOL and resource implications after
reatment. Several authors have looked at the relationship of
reatment-related toxicities and QOL for HNC patients con-
idering xerostomia to be the primary determinant of long
erm toxicity in survivors. Langendijk et al. reported that
ysphagia was the strongest determinant of overall QOL fol-
owing 3D conformal radiation therapy.4 In a prior institutional
tudy, 38.5% of patients with loco regionally advanced HNC
reated with definitive CRT with increasing age had composite
ysphagia.5 Swallowing dysfunction compromises QOL and
s found to be associated with anxiety, depression, isolation
nd loss of social relationships.6 The advanced techniques of
adiation are mainly aimed at improving toxicity profile and,
hereby, QOL. With the advent of intensity modulated radia-
ion therapy (IMRT), the structures responsible for swallowing
unction can be spared without compromising the target vol-
me  coverage.
.  Aim
he aim of this study is to correlate the dose received by the
idline swallowing structures by sparing it by the IMRT tech-
ique and the grade of dysphagia at baseline, during treatment
nd follow-up up to maximum six years following definitive
nd adjuvant radiation therapy with or without concurrent
hemotherapy.
.  Materials  and  methods
his prospective study was conducted on 30 histologically
roven HNC patients undergoing IMRT,  either radical or adju-
ant with or without concurrent chemotherapy between
ctober 2012 and March 2014, following ethical clearance and
nformed consent. The baseline dysphagia score prior to start-
ng radiation was recorded based on the RTOG criteria. All
he patients were immobilized using an aquaplast cast with
ppropriate head rest. Contrast enhanced planning comput-
rized tomography (CT) images of 3 mm slice thickness were
cquired from the vertex to carina.The gross tumour volume (GTV) was delineated taking into
ccount the clinical examination, videolaryngoscopy/direct
aryngoscopy findings and CT scan. The clinical target vol-
me  (CTV) and planning target volume (PTV) were createdFig. 2 – Contouring of larynx.
according to institutional guidelines. Along with the other
organs at risk in HNC, with regards to the swallowing appa-
ratus, the following anatomical structures were identified
and delineated: the constrictor muscles (Fig. 1), the larynx
(Fig. 2) and the oesophagus (Fig. 3). The oesophagus was
contoured with its caudal-most extent 2 cm below the caudal-
most extent of the target volume in the head and neck.The components of the above swallowing apparatus were
united and labelled as midline swallowing structure. The
parts of the midline swallowing structure which were out-
side the PTV were delineated and labelled separately as <45 Gy
656  reports of practical oncology and radiotherapy 2 4 ( 2 0 1 9 ) 654–659
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I 5 (17)Fig. 3 – Contouring of oesophagus.
constraint swallowing structure and mean dose constraint of
<45 Gy was given, although it was not a strict criterion to
achieve it. The swallowing structure which was within the PTV
was irradiated with no attempt to spare or reduce the dose.
IMRT  treatment technique was planned using the Prowess ver-
sion 4.7 and Oncentra treatment planning system. Concurrent
weekly Cisplatin chemotherapy was administered wherever
indicated. The mean dose to the <45 Gy constraint swallowing
structure was assessed using dose volume histogram (DVH).
Dysphagia was assessed at baseline, regular weekly intervals
during the course of radiation and six weeks after completion
of treatment and follow-up for up to maximum six years using
RTOG criteria. The dose to the <45 Gy constraint swallowing
structure was correlated with the degree of dysphagia.
3.1.  Statistics
Descriptive and inferential statistical analysis has been
carried out in the present study. Results on continuous mea-
surements are presented on mean ± SD (Min- Max) and results
on categorical measurements are presented in Number (%).
Significance is assessed at the 5% level. The statistical soft-
ware.  namely SAS 9.2, SPSS 15.0, stata 10.1, MedCalc 9.0.1,
Systat 12.0 and R environment version 2.11.1 were used for
the analysis of the data and Microsoft word and excel have
been used to generate the graph and tables. Fishers exact test
was used to analyse the results.
4.  ResultsThe patient characteristics are shown in Table 1. The mean
age was 57 years with majority of the primary (36.7%) being
oral cavity tumours followed by oropharynx (30%). SquamousII 9 (30)
III 7 (23)
IV 9 (30)
cell carcinoma was the most common histology. Eight patients
(27%) had history for alcohol consumption, 13 (43%) were
smokers and 8 (27%) patients were tobacco chewers. Four-
teen (47%) underwent surgery followed by adjuvant radiation
and 16 (53%) patients received at least one cycle of concurrent
chemotherapy.
4.1.  Correlation  of  the  dose  to  swallowing  structure
and dysphagia
The <45 Gy constraint to swallowing structures was achieved
in 13 (43.3%) patients. The mean dose was in the range of
4550 Gy in five patients (16.6%) and was >50 Gy in 12 patients
(40%).
The subjective assessment of dysphagia was done using
RTOG criteria at baseline i.e., before starting CRT, weekly
during the course of radiation, at 6 weeks following comple-
tion and during follow up for minimum of four years and
maximum six years. Comparison of weekly dysphagia grades
during the course of radiation between the groups of patients
receiving <45 Gy, 4550 Gy and >50 Gy mean dose to <45 Gy con-
straint volume showed no statistical difference. The baseline
grade of dysphagia in all the three groups was 0.47 ± 0.63. There
was a gradual weekly increase in grade subsequently in all the
three groups increasing from 0.7 ± 0.65 to 2.2 ± 0.57 at week 6 of
radiation. However, there was no statistically significant dif-
ference between the three groups with a mean p value of 0.48.
Dysphagia assessment at six weeks post radiation therapy was
done, five (16.7%) patients had grade two dysphagia and one
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Table 2 – Comparison between dysphagia at 6 weeks post RT with dysphagia during the last week of radiation.
Mean dose to DARS
<45 Gy 4550 Gy >50 Gy
Dysphagia grade during the last week of radiation 2.09 ± 0.54 2.40 ± 0.55 2.25 ± 0.62
Dysphagia Grade at 6 weeks post RT 0.54 ± 0.52 0.60 ± 0.89 1.08 ± 1.08
p value 0.00001 0.021 0.004
Table 3 – Results from selected series regarding late toxicity in the head and neck cancer patients treated with radiation
therapy.








1 IMRT De Arruda et al.17 50 18 86 92 6
2 IMRT Lee et al.18 41 31 100 100 12



































4 3DCRT Denie et al. 44 60 
5 3DCRT Huguenin et al20 224 39 
6 IMRT Our study 30 30 
3.3%) patient had grade three dysphagia. Ten (33.3%) patients
ad grade one dysphagia; the remaining 14 (46.7%) patients
id not exhibit any grade of dysphagia. Comparison of dys-
hagia at baseline and six weeks post treatment showed no
ignificant increase in dysphagia scores.
Also, our study did not show any increase in post treatment
ysphagia between the groups which received <45 Gy, 4550 Gy.
atients who received <45 Gy showed significant reduction in
ysphagia at 6 weeks follow up when compared to the scores
t completion of radiation (Table 2) P value = 0.00001.
.2.  Correlation  of  independent  factors  to  dysphagia
part from radiation dose to the swallowing structure, the
mpact of factors such as smoking, alcohol, tobacco chew-
ng, site of primary, T stage, N stage, surgery, concurrent
hemotherapy and neo-adjuvant chemotherapy on post treat-
ent dysphagia was determined. Among these factors, higher
 stage and addition of neo- adjuvant chemotherapy had a
ignificant correlation with dysphagia six weeks post treat-
ent. In a higher T stage, due to a higher tumour burden
ith increased volume of PTV, more  of the swallowing struc-
ure was invariably included in the PTV resulting in increased
ysphagia scores.
.3.  Follow  up
ut of the 30 patients, 10 patients expired and 7 patients were
ost to follow up, the remaining 13 patients were followed up
or maximum six years. The last follow up was in August 2018.
en patients were disease free and had normal swallowing
unction and 3 patients were on liquid diet. The mean dose to
wallowing structure in these 10 and 3 patients was <45 Gy and
50 Gy respectively. All the patients whose dose to the swal-
owing structure was <45 Gy had normal swallowing function
t 6 year follow-up and those who  received >50 Gy had grade
II dysphagia which was statistically significant with a p value




The present prospective study was designed to evaluate the
degree of dysphagia in HNC patients receiving radical radia-
tion by the IMRT technique. RTOG questionnaire was used to
assess dysphagia. A dose constraint of <45 Gy was prescribed
to the midline swallowing structure which was outside the
PTV volume and there was no strict criteria to achieve it. No
attempt was made to spare the swallowing structures which
were close to or within the PTV volume. Our methodology was
in accordance with the study done by Eishbruch et al, where
the authors used IMRT  to reduce dose to the midline swallow-
ing structures without any compromise on the target dose.7
The authors found a decrease in the incidence of late dyspha-
gia. Majority of the patients in the present study were in the
age group 5060 years, with a mean age of 57 years. This is
similar to a study done by Amin et al, where the median age
was 56 years.8 Oral cavity (36.7%) was the most common site
of primary tumour followed by the oropharynx (30%) in our
study group. Caglar et al.9 and Eishbrush et al.10 included only
laryngeal and oropharyngeal tumors, Peponi et al. included all
the head and neck sites similar to that of our study.11 In our
study, <45 Gy constraint was given to the swallowing structure
outside the PTV and achieving this dose constraint was not
an absolute requirement. A similar study was done by Eish-
bruch et al.; however. the dose constraint was 50 Gy to the
swallowing structure. This was based on the observation that
the lowest dose received to most of the constrictors involved
in a stricture was 50 Gy.7 Galloway et al.12 in a study describ-
ing laryngeal irradiation with midline swallowing structure
sparing IMRT,  a constraint of mean dose 50 Gy was given to
the midline swallowing structure. Even in their study, achiev-
ing the 50 Gy constraint was not an absolute requirement and
had to be compromised when the tumour was close to the
pharynx.
Feng et al. found that no aspiration events were observed
when the dose to the midline swallowing structure was kept
below 45 Gy.13 Constraint in our study is similar to that done
by Peponi et al. where the authors used mean dose constraint
of <45 Gy to the midline swallowing structure and included all
primary sites in their analysis.11
d rad
r
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This is the first prospective study where baseline dysphagia
scores were recorded and compared with weekly dysphagia
during radiation as well as long term follow up. None of the
previous studies have compared the effect of midline swallow-
ing structure sparing IMRT  during the course of radiation. The
weekly dysphagia scores did not differ significantly between
the three groups of patients i.e. <45 Gy, 4550 Gy and >50 Gy.
However, an important observation was made by Amin et al.,
namely that a dose to the swallowing structures during IMRT
was significantly lower (55.2 Gy) when a constraint was given
compared to planning without a dose constraint (62.2 Gy).8
In our study only one patient had grade 3 dysphagia (3%)
at 6 weeks post radiation. This is in contrast to a study by
Forastiere et al.14 where 23% of the patients receiving radi-
ation were only on liquid diet. The reason probably would
be that fifty percent of the patients in their study received
altered fractionation. Our patients did not receive altered frac-
tionation. In a similar study by Caglaret et al.9 32% of the
patients developed clinically significant aspiration and 37% of
the patients developed strictures. Caudell et al. on assessing
long term dysphagia following definitive radiotherapy of HNC
reported that 38.5% of patients had late severe dysphagia.5
Even higher rates of toxicity were reported by Denis et al.,
where the authors reported that 68% of patients treated with
definitive IMRT  without dose constraint to swallowing struc-
ture had grade III dysphagia.15 Peponi et al. reported similar
results with a median follow up of fifty-five months and found
9% incidence of grade III/IV toxicity, when swallowing struc-
ture sparing IMRT  was used.11 At six years follow up, our
study showed 10% incidence of grade III&IV toxicity. Results
from selected series regarding late toxicity treated with radi-
ation therapy with or without concurrent chemotherapy are
shown in Table 3. In our study, dysphagia at 6 weeks post treat-
ment was compared with baseline dysphagia. No significant
increase in dysphagia was seen when post treatment dyspha-
gia scores were compared with pre-treatment baseline scores.
This proves the effectiveness of using swallowing structure
sparing IMRT  in reducing the incidence of dysphagia. Only two
previous published studies by Schwartz et al.16 and Langendijk
et al.4They have recorded the pre-treatment dysphagia scores.
Most of the other studies were retrospective and analysed only
late dysphagia scores which have led to over-estimation of
dysphagia following radiation. Our study showed a significant
improvement in late dysphagia scores when compared with
dysphagia scores during the last week of radiation therapy
in patients who  received <45 Gy to the swallowing structure.
This is thought to represent a consequential effect of severe
acute depletion of mucosal and sub-mucosal stem cells due
to irradiation. Reduction in dose to the swallowing structure
might have led to faster recovery of mucosal cells and, in turn,
decreased dysphagia scores.
There was no correlation with the use of concurrent
chemotherapy and dysphagia scores similar to study done by
Schwartz et al.,16 Forastiere et al.,14 and Eishbruch et al.10
have reported increased incidence of late dysphagia with
the addition of concurrent chemotherapy. This could be
explained as potentiation of action of radiation by concur-
rent chemotherapy on the swallowing structures. But in those
studies, swallowing structure sparing IMRT  was not employed.
The effect of concurrent chemotherapy with the swallowingiotherapy 2 4 ( 2 0 1 9 ) 654–659
structure sparing IMRT has not been studied extensively apart
from our study.
The effect of neo-adjuvant chemotherapy on late dyspha-
gia scores has not been correlated in previous studies. In our
study, we  found a significant correlation between late dyspha-
gia scores and the addition of neoadjuvant chemotherapy to
the treatment regimen. In our study, neoadjuvant chemother-
apy was given in those patients who had a locally advanced
disease. So this might actually be an impact of a higher T stage
of the disease, as target volumes in these patients would be
considerably large with more  volume of the swallowing struc-
ture in the PTV. The limitation of our study is that the sample
size is small. Also, the impact of salivary function on dyspha-
gia score was not studied. Our study is a subjective study based
on patients reported questionnaires and objective assessment
of dysphagia with video fluoroscopy or esophagogram was not
done.
This is the first prospective study where baseline dysphagia
scores were recorded and compared with weekly dyspha-
gia during radiation as well as long term follow-up. None of
the previous studies have compared the effect of swallowing
structure sparing IMRT during the course of radiation.
6.  Conclusion
Giving a constraint to swallowing structure and limiting it
to <45 Gy resulted in earlier recovery of swallowing function
resulting in good physical, mental and social well being of the
patients when compared to those who received >45 Gy.
The dysphagia scores correlated with the dose received
by the swallowing structures. No significant increase in post
radiation dysphagia was observed when dose to swallowing
structures was limited using IMRT. Recovery from dysphagia
following completion of radiation correlated with dose to the
swallowing structures.
Future studies with a larger sample size may help in estab-
lishing the dose response relationship of midline swallowing
structures and impact of independent factors on radiation
induced dysphagia.
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